1. Stocks
  2. Eiko Lifesciences Ltd.
  3. Swot
swot-logo

Eiko Lifesciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Eiko Lifesciences Ltd. has 13 Strengths, 7 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Promoter holding increased more than 2% QoQ

Companies with no Debt

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Mid-range Performer (DVM)

Growth stocks, promoters increasing shareholding

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Companies with rising net profit margins - quarterly as well as TTM basis

Growth in Net Profit with increasing Profit Margin (QoQ)

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Volume Shockers

High PE (PE > 40)

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Declining Revenue every quarter for the past 2 quarters

Weak Momentum: Price below Short, Medium and Long Term Averages

Top Losers

Declining profitability: Falling ROCE

Stocks Underperforming their Industry Price Change in the Quarter

Companies with improving valuation scores after share price falls

Promoters increasing shareholding QoQ

Rising Delivery Percentage Compared to Prev Day

Significant Change in Promoter Shareholding - Latest Quarter

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Quarterly Net Profit with falling Profit Margin (YoY)